Correction to “Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys”

Heng Li,Lei Guo,Huiwen Zheng,Jing Li,Xin Zhao,Jiaqi Li,Yan Liang,Fengmei Yang,Yan Zhao,Jing Yang,Mengyi Xue,Yuanyuan Zuo,Jian Zhou,Yanli Chen,Zening Yang,Yanyan Li,Weihua Jin,Hongzhe Shi,Zhanlong He,Qihan Li,Longding Liu
DOI: https://doi.org/10.1021/acs.bioconjchem.1c00424
IF: 4.7
2021-01-01
Bioconjugate Chemistry
Abstract:ADVERTISEMENT RETURN TO ISSUEPREVCorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to “Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys”Heng LiHeng LiMore by Heng Lihttps://orcid.org/0000-0002-6352-2469, Lei GuoLei GuoMore by Lei Guo, Huiwen ZhengHuiwen ZhengMore by Huiwen Zheng, Jing LiJing LiMore by Jing Li, Xin ZhaoXin ZhaoMore by Xin Zhao, Jiaqi LiJiaqi LiMore by Jiaqi Li, Yan LiangYan LiangMore by Yan Liang, Fengmei YangFengmei YangMore by Fengmei Yang, Yurong ZhaoYurong ZhaoMore by Yurong Zhao, Jinling YangJinling YangMore by Jinling Yang, Mengyi XueMengyi XueMore by Mengyi Xue, Yuanyuan ZuoYuanyuan ZuoMore by Yuanyuan Zuo, Jian ZhouJian ZhouMore by Jian Zhou, Yanli ChenYanli ChenMore by Yanli Chen, Zening YangZening YangMore by Zening Yang, Yanyan LiYanyan LiMore by Yanyan Li, Weihua JinWeihua JinMore by Weihua Jin, Haijing ShiHaijing ShiMore by Haijing Shi, Zhanlong He*Zhanlong HeMore by Zhanlong He, Qihan Li*Qihan LiMore by Qihan Li, and Longding Liu*Longding LiuMore by Longding LiuCite this: Bioconjugate Chem. 2021, 32, 10, 2268Publication Date (Web):September 9, 2021Publication History Published online9 September 2021Published inissue 20 October 2021https://doi.org/10.1021/acs.bioconjchem.1c00424Copyright © 2021 American Chemical Society. This publication is licensed under CC-BY-NC-ND 4.0. License Summary*You are free to share (copy and redistribute) this article in any medium or format within the parameters below:Creative Commons (CC): This is a Creative Commons license.Attribution (BY): Credit must be given to the creator.Non-Commercial (NC): Only non-commercial uses of the work are permitted. No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited. View full license*DisclaimerThis summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials. This publication is Open Access under the license indicated. Learn MoreArticle Views893Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (650 KB) Get e-AlertscloseSUBJECTS:Nanoparticles,Receptors,SARS-CoV-2,Serum,Vaccination Get e-Alerts
What problem does this paper attempt to address?